With the introduction of personalized vaccines, the UK is at the start of a new era in the fight against cancer. National Health Service (Nohs). These vaccines are intended for patients who have already undergone cancer surgery to prevent recurrence of the disease.
Innovative process It involves using genetic material from a patient's tumor to develop a vaccine designed to strengthen the immune system against cancer cells. The first patient to receive this pioneering treatment was 55-year-old Elliot Pfebwe, a father of four with colon cancer at the Queen Elizabeth Hospital in Birmingham. His experience marked what the British press described as a “historic moment” in the medical landscape.
Although the technology is still developing and no vaccine has been approved by health regulators, NHS leaders They expressed their determination to make these new treatments as widely accessible as possible, thus giving new hope to cancer patients.
Also read other news Nova News
Click here and get updates on WhatsApp
Follow us on Nova News social networks Twitter, LinkedIn, Instagram, telegram
“Certified food fanatic. Extreme internet guru. Gamer. Evil beeraholic. Zombie ninja. Problem solver. Unapologetic alcohol lover.”
More Stories
US energy production hits new record
Rugby: Former Australia captain Michael Hooper has ended his career after his dream of competing in the Olympics evaporated.
Despite its lack of discipline, Australia prevailed against Georgia